Siemens Healthineers is preparing its Diagnostics business to become a standalone organization, according to an announcement.

The company announced the in vitro diagnostics business will operate under the name Olyrian Diagnostics. At the same time, Siemens Healthineers has announced it will change its name to 'Healthineers'. The two transitions will take place in parallel. 

Establishing Olyrian is the next step in preparing Diagnostics to operate as a standalone organization. The transition is expected to be completed by mid-2028. From patient draw to population health, Olyrian will deliver diagnostic solutions for laboratory and point-of-care testing. According to Siemens, Olyrian’s purpose – powering human potential at the heart of care – reflects a singular focus on in vitro diagnostics and a commitment to combine intelligent technology with the expertise of the people who make, interpret, and act on diagnostic information. 

While working toward being a standalone organization, Olyrian will remain part of Siemens Healthineers. As of today, there is no change to products and services, contracts, service levels, or customer points of contact. Updates will be provided as the carve-out evolves, and any future changes will be communicated directly. 

Visit Siemens Healthineers for more information